The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. From Wikipedia
The voluntary program will test post-sale rebate models instead of upfront discounts for selected Medicare-negotiated drugs.
